Trial
NCT03260504
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
Merck Sharp & Dohme LLC; Prometheus Laboratories
Condition
Advanced Clear Cell Renal Cell Carcinoma
Intervention
Aldesleukin
Why stopped
Insufficient funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-08